Elvis J. Alonso in

Elvis J. Alonso

Evaluator · DISC type cds
Vice President, Research and Early Development Operations at Alnylam Pharmaceuticals
📍 Cambridge, Massachusetts, United States

Experienced Research Operations leader with an MBA from Northeastern University and over ten years of experience in the pharmaceutical and biotech industry. He excels in strategic decision-making, financial analysis, and leading global projects. Colleagues describe him as a hard-working thought leader and a dedicated team player.

He has a strong foundation in oncology research from his early career at organizations including the Dana-Farber Cancer Institute. He also held strategic consulting and global marketing roles at Baxter International.

Read the full overview →
Experience
13 Years
Current Role
Vice President, Research and Early Development Operations
Job Level
Senior
Location
Cambridge, Massachusetts, United States
Personality Overview

How Elvis shows up

Hard To Convince
Quality Focused
Fast But Analytical

They have a unique set of diverse traits where they are decisive and methodical but can sometimes be extra cautious and skeptical They focus on the results, but can still be quite procedural and analytical about how to get there They are not very likely to become strong advocates of your product or service

Priorities

Topics Elvis cares about

Research Operations
Leads Research and Early Development Operations at Alnylam, with a track record in similar roles at Moderna and Takeda, focusing on strategic and financial goals.
Team Building
Actively recruits for his team, seeking to hire directors and associates for lab operations and preclinical study management to support organizational growth.
+4 more topics Login to view topics
Career

Work history

7-2022
Vice President, Research and Early Development Operations
Alnylam Pharmaceuticals
1-2020 - 7-2022
Senior Director, Research and Early Development Operations
Alnylam Pharmaceuticals
8-2017 - 1-2020
Director, Research and Early Development Operations
Alnylam Pharmaceuticals
2-2015 - 8-2017
Director, Research Operations
Moderna Therapeutics
10-2013 - 2-2015
Associate Director, Discovery Operations
Takeda Pharmaceuticals
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2003 - 2005
MBA
D'Amore-McKim School of Business at Northeastern University
1994 - 1998
BA
Boston University
Social presence
in
Behavioral profile

DISC profile (public)

c

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals.

Juliette Jones
Juliette Jones
Head of Commercial Training & Development - International
Alnylam Pharmaceuticals
 Sharon Haynes Meakin, Ph.D.
Sharon Haynes Meakin, Ph.D.
Director, Head of Global Medical Affairs Training
Alnylam Pharmaceuticals
 Garrett Ingrando
Garrett Ingrando
Head of Marketing for North America
Alnylam Pharmaceuticals

More profiles

Discover additional public profiles from our index.

Josh Gavos
Josh Gavos
Account Executive
Texas AirSystems
 Sven Bilke
Sven Bilke
Director Oncology Bioinformatics
Illumina
DM
Darío Malpica
Owner
Universidad Contemporánea
 Karen Bunting
Karen Bunting
Senior Director, R&D Operations
10x Genomics
Unlock the full playbookSee exactly how to sell to Elvis. Free, 10 seconds.